Gene: FOXA2
Official Full Name: forkhead box A2provided by HGNC
Gene Summary: This gene encodes a member of the forkhead class of DNA-binding proteins. These hepatocyte nuclear factors are transcriptional activators for liver-specific genes such as albumin and transthyretin, and they also interact with chromatin. Similar family members in mice have roles in the regulation of metabolism and in the differentiation of the pancreas and liver. This gene has been linked to sporadic cases of maturity-onset diabetes of the young. Transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Oct 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04526 | FOXA2 Knockout cell line (HEK293) | Human | FOXA2 | 1:3~1:6 | Negative | Online Inquiry |
FOXA2 Gene Knockout Cell Lines are engineered cellular systems that have had the FOXA2 gene disrupted through precise genetic modifications. This gene encodes a transcription factor that plays a pivotal role in the regulation of developmental processes, particularly in the context of metabolism, cellular differentiation, and organogenesis. The knockout of FOXA2 facilitates the study of its function and mechanism in a controlled environment, allowing researchers to explore the downstream effects on gene expression and cellular pathways.
These cell lines operate by utilizing CRISPR-Cas9 technology or other advanced gene-editing techniques to achieve targeted gene disruption. By creating a deficiency in FOXA2 expression, researchers can investigate the cellular responses and compensatory mechanisms activated in its absence. This model is invaluable for elucidating the gene's role in diseases such as obesity, diabetes, and certain cancers, where FOXA2 is implicated in metabolic regulatory processes.
The scientific importance of FOXA2 knockout models extends across various research areas, including developmental biology, metabolism, and therapeutic target validation in clinical settings. Their ability to provide insights into transcriptional networks and metabolic dysregulation makes them essential tools for discovering novel interventions for diseases characterized by metabolic abnormalities.
Compared to conventional gene knockout methods, our FOXA2 Gene Knockout Cell Lines offer greater specificity and efficiency, significantly reducing the time required for experimentation and increasing reproducibility of results. The availability of these genetically modified models also positions researchers at the forefront of cutting-edge science, allowing for more robust experimentation in a variety of applications, from drug screening to fundamental biological research.
By utilizing FOXA2 Gene Knockout Cell Lines, researchers and clinicians gain access to precise tools that advance their studies, providing the opportunity to uncover vital pathways involved in health and disease states. With our commitment to innovation and quality, we ensure that our products streamline research efforts and enhance scientific understanding, backed by our extensive expertise in genetic engineering and cell line development.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.